1. Home
  2. VCEL

VCEL

Vericel Corporation

as 12-18-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Founded: 1989 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: N/A IPO Year: 1997
Target Price: $61.83 AVG Volume (30 days): 351.0K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.07 EPS Growth: N/A
52 Week Low/High: $32.31 - $61.49 Next Earning Date: 11-07-2024
Revenue: $226,844,000 Revenue Growth: 22.48%
Revenue Growth (this year): 23.82% Revenue Growth (next year): 22.51%

VCEL Daily Stock ML Predictions

Stock Insider Trading Activity of Vericel Corporation (VCEL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Wotton Paul K VCEL Director Dec 4 '24 Sell $58.72 2,600 $152,672.00 27,402
Hopper Jonathan Mark VCEL Chief Medical Officer Dec 2 '24 Sell $58.72 10,000 $587,200.00 58,371
ZERBE ROBERT L MD VCEL Director Nov 22 '24 Sell $60.00 2,500 $150,000.00 26,595
Colangelo Dominick VCEL President and CEO Nov 13 '24 Sell $54.75 35,000 $1,916,250.00 220,937
MCLAUGHLIN KEVIN F VCEL Director Nov 13 '24 Sell $55.54 7,000 $388,780.00 11,900
ZERBE ROBERT L MD VCEL Director Nov 11 '24 Sell $56.25 5,000 $281,250.00 26,595
Colangelo Dominick VCEL President and CEO Oct 16 '24 Sell $40.86 35,000 $1,430,100.00 220,937
GILMAN STEVEN C VCEL Director Oct 16 '24 Sell $41.36 5,833 $241,252.88 11,000
GILMAN STEVEN C VCEL Director Oct 2 '24 Sell $40.35 5,833 $235,361.55 11,000
SIEGAL JONATHAN VCEL Principal Accounting Officer Sep 30 '24 Sell $41.90 568 $23,799.20 1,124

Share on Social Networks: